Universal Ibogaine Advises of Filing Application for Management Cease Trade Order

Core Viewpoint - Universal Ibogaine Inc. has applied for a temporary management case trade order (MCTO) due to delays in filing its audited financial statements and related documents, which are expected to be completed by the end of January 2026 [1][2][3]. Group 1: Company Situation - The company is unable to file its audited consolidated financial statements for the financial year ended July 31, 2025, by the deadline of November 28, 2025 [2]. - The delay in the required annual filings is attributed to limited financial resources for completing the audit [3]. - If granted, the MCTO will prohibit trading of the company's securities by the CEO and the currently vacant CFO until the required filings are completed [1][3]. Group 2: Compliance and Reporting - During the MCTO period, the general public can still trade the company's common shares [1]. - The company will comply with alternative information guidelines set out in NP 12-203, which includes issuing bi-weekly default status reports until the required filings are made [4]. Group 3: Company Overview - Universal Ibogaine Inc. aims to transform addiction treatment using medicalized ibogaine, focusing on a planned Canadian clinical trial for opioid use disorder [5].